Steroid minimization immunosuppression protocol using basiliximab in adult living donor liver transplantation for hepatitis C virus‐related cirrhosis

Publisher： John Wiley & Sons Inc

E-ISSN： 1872-034x|45|12|1178-1184

ISSN： 1386-6346

Source： HEPATOLOGY RESEARCH, Vol.45, Iss.12, 2015-12, pp. : 1178-1184

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Patient with decompensated hepatitis C virus–related cirrhosis delisted for liver transplantation after successful sofosbuvir‐based treatment

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 3, 2015-03 ,pp. : 408-409

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of basiliximab in liver transplantation for patients with hepatitis B virus‐related diseases: a single centre study

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. S183, 2015-05 ,pp. : 35-42

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interferon Reduces the Risk of Hepatocellular Carcinoma in Hepatitis C Virus-Related Chronic Hepatitis/Liver Cirrhosis

By  

Oncology, Vol. 78, Iss. 1, 2010-07 ,pp. : 17-23

Karger

Access to resources Recommend Favorite

Radiofrequency Ablation as a Palliative Treatment of Primary Liver Sarcoma in an Inoperable Patient with Hepatitis C Virus-Related Cirrhosis

By  

Oncology Research and Treatment, Vol. 32, Iss. 8-9, 2009-07 ,pp. : 509-512

Karger

Access to resources Recommend Favorite

Outcomes of living donor liver transplantation for hepatitis C virus‐positive recipients in Japan: results of a nationwide survey

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 27, Iss. 8, 2014-08 ,pp. : 767-774

John Wiley & Sons Inc

Access to resources Recommend Favorite